The global flow cytometry system market was valued at USD 4,298.1 Million in 2019 and is projected to reach USD 9,452.6 Million by 2027, expanding at a CAGR of 10.0% during the forecast period. Flow cytometry is technique, which is used to measure the physical and chemical characteristics of cells. Flow cytometry systems are the instruments, which are used for analyzing the quantitative of cells and for analyzing chromosomes, m-RNA, recombinant proteins, and other molecules, which are suspended in a fluid. Flow cytometry technique is based on the principle of the measurement of scattering of light by the particles. The fluorescence light is passed through the cell. The deflection of the light occurs, according to the complexity and size of the particle. Forward-scattered light (FSC), and side-scattered light (SSC) are two methods of deflecting the light. The measurements of FSC and SSC are used for the differentiation of cell types in a heterogeneous cell suspension, while fluorescent markers are used for determining the proteins or nucleic acids. Fluorescence pattern of each cell suspension, which are mixed with FSC and SSC, can be used to identify the cells and to count their percentage. For the detection of specific antibodies, cells are coated with fluorochrome-conjugated antibodies specific to the surface markers present on different cells. Flow cytometry techniques are used for identifying hematological malignancies. Cell size, granularity of the cell, and intracellular proteins can be identified using flow cytometry. Flow cytometry systems are used for precise analysis of small population of cells at high speed.
Increased Use of Artificial Intelligence (AI) in Flow Cytometry Systems
The advent of new technology, has led to the adoption of the artificial intelligence (AI) for the detection and separation of the cells, molecules, and deoxyribonucleic acid (DNA), using a software, which is used in the flow cytometry systems process. AI is used in analyzing the images, and also interprets the complex data. Artificial intelligence uses programs and algorithms for the separation and analysis of cells. AI, using the deep learning algorithms, simplifies the multimodal images, and reduces the variability in the data. The reduction in the variability in the data, enhances the quality of the data. The use of imaging flow cytometry systems combines brightfield, darkfield, and fluorescence-based detection all in one platform. AI, finds its use in several applications, including, studies designed to monitor multiple subcellular compartments, or to locate and quantify the distribution of signaling molecules on, in, or between cells. Technological advancements and rise in the adoption of the AI in biotechnology and pharmaceutical industries are some of the factors, which boosts the adoption of AI in flow cytometry.
Increase in Government Funding for Pharmaceutical and Biotechnology Companies
Governments are investing in research for the development of novel drugs and techniques for determining vaccines and drugs, thus boosting research and development (R&D) in the pharmaceutical and biotechnology industries. The investments boost the development of innovative products. Several research biotechnology and pharmaceutical companies have installed flow cytometers for the detection of recombinant proteins, and cell cycles. Government investments reduce the burden on drug manufacturing companies, thus boosting the adoption of the flow cytometers. The government of the UK, has increased funding for R&D. The government is focusing on the development of new drugs for biosimilars and personalized medicines, which boost the adoption of flow cytometers for the determination of mechanism of action of the drugs.
High Costs of Flow Cytometry Systems
Flow cytometers are widely used in pharmaceutical and biotechnology companies, for the manufacturing of drugs. Flow cytometers are used for the monitoring of diseases and are used in the diagnostic centers and hospitals. High costs of the flow cytometers is one of the major factor, which hampers the demand for the flow cytometers. Large amount of capital is required for the purchase of the flow cytometers. Several companies have funding limitations, which hampers the demand for the flow cytometers. Costs of the reagents, which are used for the detection of antibodies, are also high, which hampers the demand for the flow cytometers. These are some of the factors, which hinders the demand for the flow cytometers.
Dearth of Skilled Professionals
Dearth of skilled personnel is one of the major factors which hampers the market. Flow Cytometry Systems requires qualified personnel for analysis of the molecules, during the flow cytometry process. Skilled personnel is required for the implementation of new techniques. However, several people are unqualified or under skilled for the processes, thus hampering the market. Several workers are unaware of the process and this may have an impact on the final products. The dearth of skilled labors is among the major factor, which hampers the adoption of glow cytometers in research institutes and organizations.
On the basis of technology, the market is segmented into cell-based flow cytometry system, and bead- based flow cytometry systems. The cell-based flow cytometry systems accounted for 78.9% share of the market in 2019. The rapid growth of the segment is attributed to the rise in the demand for the analysis of the cells, and identification of the cell population which are some of the factors, which contributes for the growth of the segment. Additionally, the cell-based flow cytometry system is widely available and convenient to use, which is one of the factors, which contributes for the growth of the market.
In terms of products and services, the global flow cytometry systems market is divided into reagents and consumables, instruments, services, software, and accessories. The instruments segment is sub-segmented into cell analyzers and cell sorters. Reagents, and consumables segment is anticipated to expand at a CAGR of 10.4% during the forecast period. Rise in the use of the reagents, and consumables, for the detection of the antibodies, which are some of the factors, which contributes for the demand for the reagents and consumables.
Based on applications, the global flow cytometry systems market is divided into research applications, immunology, clinical applications, and industrial applications. The research applications segment is further segregated into pharmaceutical and biotechnology, drug discovery, stem cell research, and in-vitro toxicity. The pharmaceutical and biotechnology segment is anticipated to account for a significant share of the market during the forecast period, while the drug discovery segment is estimated to expand at a substantial CAGR during the forecast period. Based on research applications, the market is segmented into cancer diagnostics, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications. Cancer diagnostic segment is expected to have a significant share of the market, owing to the rise in the prevalence of cancer, which has led to the rise in the adoption of the flow cytometry systems for the prognosis of the diseases.
In terms of end-users, the global flow cytometry systems market is segregated into commercial organizations, hospitals, academic institutes, and clinical testing labs. The clinical testing labs segment is projected to constitute a large share of the market during the forecasts period, while the hospitals segment is anticipated to expand at significant pace during the forecast period. Flow cytometry systems techniques is used for the analysis of the diseases. Flow cytometers are used to diagnose various types of cancer, which in turn, boost their adoption in the hospitals.
In terms of regions, the global flow cytometry system market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific is projected to expand at a CAGR of 10.9% during the forecast period. Rise in presence of several manufacturers, is thereby boosting the growth of the flow cytometry system market in Asia Pacific.
Some frequently asked quetions about this report!
Additional company profiles can be provided on request.
Yes, the report covers product specific information such as cell-based flow cytometry systems, and bead-based flow cytometry systems, etc.
According to this Growth Market Reports report, the market from flow cytometry system market shall probably to register a CAGR of 10.0% during forecast period 2020-2027, with an anticipated valuation of USD 9,452.6 million by the end of the 2027.
The rising adoption of AI in flow cytometry and rise in the investments in research and development, for the detection of diseases are expected to drive the market growth during forecast period.
Biotech and pharmaceutical industries, research and academic Institutes, hospitals and diagnostic centers are the key application that are driving the flow cytometry system market.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The market is expected to project a growth of over 12.6% in 2020 owing to the positive impact of COVID-19 pandemic on the flow cytometry system market. The rising adoption of flow cytometry system by biopharmaceutical companies boost the growth of the segment.
The base year considered for the global flow cytometry system market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.
Major manufactures includes Danaher Corp, and Becton, Dickinson and Company are the key players operating in the market.
Some other reports from this category!